| No headlines available for SBHIX. |
| | | Morningstar Overall Rating: |  | | Total Assets: | 8.95M | | Category: | Health | | Total Expense Ratio: | % |
|
| PERFORMANCE & RISK | 30-Nov-09 |
| YTD Return: | 31.93% | | 5y Avg Return: | 3.84% | | Rank in Category (ytd): | 4 | | % Rank in Category (ytd): | 2.42% | | Beta (3y): | 0.75 | | Morningstar Risk Rating: | Below average |
|
| The investment seeks long-term growth of capital. The fund invests at least 80% of total assets in equity securities of U.S. and foreign healthcare companies and biotechnology companies, regardless of their stock market value (or market capitalization), including common stocks, preferred stocks, securities convertible into common stocks and warrants. The fund is nondiversified. | | | Fund Profile |
|
Help
0.10 (0.64%) 
Summary
Add SBHIX to Portfolio 
Download Data
